CD138 Is Expressed in Different Entities of Salivary Gland Cancer and Their Lymph Node Metastases and Therefore Represents a Potential Therapeutic Target

Advanced salivary gland carcinomas (SGC) often lack therapeutic options. Agents targeting CD138 have recently shown promising results in clinical trials for multiple myeloma and a preclinical trial for triple-negative breast cancer. Immunohistochemistry for CD138 was performed for all patients who h...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayer, Marcel, Nachtsheim, Lisa, Hoffmann, Franziska, von Eggeling, Ferdinand, Guntinas-Lichius, Orlando, Prinz, Johanna, Klußmann, Jens Peter, Quaas, Alexander, Arolt, Christoph, Wolber, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409357/
https://www.ncbi.nlm.nih.gov/pubmed/36012301
http://dx.doi.org/10.3390/ijms23169037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409357/
https://www.ncbi.nlm.nih.gov/pubmed/36012301
http://dx.doi.org/10.3390/ijms23169037

Ejemplares similares